|
|
| Sound News | Press
Releases | Archives | Week In
Review | Editorials
| Articles | |
|
![]() |
|
||||
|
|||||
Company Reports Quarterly Earnings Per Share of $0.01 and Year-to-Date Earnings Per Share of $0.01 |
|
SANTA ANA, Calif., Nov. 13 /PRNewswire-FirstCall/
-- SRS Labs, Inc. (NASDAQ:SRSL) , a leading provider of audio, voice
and semiconductor technology solutions, today reported financial
results for its third quarter and nine months ended September 30,
2003. For the three months ended September 30, 2003, the company
reported consolidated revenue of $4,886,394, a decrease of 9.7 percent
over consolidated revenue of $5,411,613, for the same quarter in 2002.
For the quarter ended September 30, 2003, the company reported a net
income of $118,826, or $0.01 earnings per share, compared to a net
income of $595,774, or $0.05 earnings per share, for the same period
last year. Technology licensing revenues decreased 8
percent over the same quarter last year and semiconductor revenues
decreased 2 percent over the same period in 2002. Consolidated gross
margin improved to 75 percent for the quarter ended September 30,
2003, compared to 72 percent for the same period last year. For the nine months ended September 30, 2003,
the company reported consolidated revenue of $13,882,614, an increase
of 6.8 percent over consolidated revenue of $12,995,353, for the same
period in 2002. For the nine months ended September 30, 2003, the
company reported a net income of $127,478, or $0.01 earnings per
share, compared to a net income of $109,597 or $0.01 earnings per
share, for the same period last year. The company's cash and
investments position totaled $21.9 million on September 30, 2003. Janet Biski, chief financial officer of SRS Labs
said, "As we have previously noted in our financial filings, one
of the risks associated with our licensing business is product and
customer concentration. From time to time, certain original equipment
manufacturer (OEM) and semiconductor manufacturer customers may
account for a significant portion of revenue from a particular product
application. In the third quarter of 2003, licensing revenues were
adversely affected by the decision of one of our manufacturing
customers who accounted for a significant portion of the company's
licensing revenues from the sales of DVD players, to discontinue the
use of our technologies in the traditional DVD player segment because
of pricing pressures in the DVD market. We were able to offset a
majority of the decrease in the third quarter as a result of revenues
generated from new product categories and the increased penetration of
SRS Labs' technologies in our home theater market. These revenues
reflect upon the company's strategy to diversify its customer
base." Biski continued, "Our gross margins for our
ASIC business decreased four percent from last year, reflecting
competitive pricing in the semiconductor market. In addition, our
operating expenses grew as a result of our promotional investments to
support our OEMs, and diversification into new markets. We also made
investments in R&D to develop new technologies and semiconductor
solutions in all of our key markets." Thomas C. K. Yuen, SRS Labs' chairman and CEO,
said: "In the third quarter, we saw the positive results of our
strategy to diversify our licensing and semiconductor businesses, even
as revenues decreased from last year. We developed new chip solutions
with our patented audio, voice and surround sound technologies for
sale to manufacturers in the Asia Pacific region. Our licensing
efforts are focused on continuing the diversification of our customer
base and expanding our technology offerings across new semiconductor
platforms, such as ST Microelectronics and PacketVideo, to service a
larger portion of the consumer electronics marketplace." Some key highlights for the quarter ended September 30, 2003 include:
-- Home Theater & Consumer Audio - Expanded relationship with Philips
Semiconductor for the global TV market, and Samsung, Sampo, and
Nakamichi for the fast-growing flat panel TV segment
-- Portable and Wireless Devices - Announced an agreement with NEC for
mobile phones and formed partnerships with Intel, ARM, and PacketVideo
for portable and wireless devices
-- ValenceTech - Design wins with Sony and Philips for ASP standard chips
featuring SRS technologies
Yuen continued, "I am pleased with the
initial signs of success in our diversification strategy. We feel that
the strong foundation we are building this year will help insulate us
against product and customer concentration issues and put us in a
better position to capitalize on opportunities in growing markets,
such as cell phones and flat panel TVs." In conjunction with SRS Labs' (NASDAQ:SRSL)
third quarter results, investors will have the opportunity to listen
to the conference call live online through the investor section of the
SRS website or through the following links: http://www.firstcallevents.com/service/ajwz392961981gf12.html
or http://www.vcall.com/CEPage.asp?ID=85116
today, November 13, 2003 at 3pm EDT or link to the conference from the
Investor section of SRS Labs' website at www.srslabs.com. About SRS Labs, Inc. Celebrating a decade in audio technology
innovation, SRS Labs has become a recognized leader in the advancement
of audio and voice technology. The company works with the world's top
manufacturers to provide a richer entertainment experience through
patented sound techniques. SRS Labs' technologies can be heard through
products ranging from televisions, DVD players, cell phones, car audio
systems and computers. The company also offers hardware and software
tools to professionals and consumers for the production and broadcast
of content featuring SRS Labs' technologies. SRS Labs' wholly owned
subsidiary, ValenceTech, is located in Hong Kong and provides custom
ASICs and standard ICs to leading manufacturers worldwide. Based in
Santa Ana, Calif., the company also has licensing representation in
Hong Kong, Japan, Europe, and Korea. For more information about SRS
Labs, Inc. please visit www.srslabs.com. The information on the
above-referenced websites is not incorporated by reference into this
press release. Except for historical information contained in
this release, statements in this release, including those of Mr. Yuen
and Ms. Biski, are forward-looking statements and projections (which
include statements concerning plans and objectives of management for
future operations) that are based on management's belief, as well as
assumptions made by, and information currently available to,
management. While the Company believes that its expectations are based
upon reasonable assumptions, there can be no assurances that the
Company's goals and strategy will be realized. Numerous factors
(including risks and uncertainties) may affect the Company's actual
results and may cause results to differ materially from those
expressed in forward-looking statements made by or on behalf of the
Company. Some of these factors include the general market conditions
concerning the overall semiconductor business, the acceptance of new
SRS Labs' products and technologies, the impact of competitive
products and pricing, the timely development and release of
technologies by the Company, product and customer concentration risks,
general business and economic conditions, especially in Asia, and
other factors detailed in the Company's Form 10-K and other periodic
reports filed with the SEC. SRS Labs specifically disclaims any
obligation to update or revise any forward-looking statement whether
as a result of new information, future developments or otherwise. Investor Contact:
Tami Yanito
(949) 442-1070 x 3093
tami@srslabs.com.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2003 2002 2003 2002
Revenues:
Licensing $1,854,707 $2,008,554 $6,441,297 $5,240,117
Semiconductor 2,884,248 2,945,687 7,063,008 6,782,127
Other 147,439 457,372 378,309 973,109
Total revenues 4,886,394 5,411,613 13,882,614 12,995,353
Cost of sales 1,242,436 1,505,290 2,812,569 3,413,450
Gross margin 3,643,958 3,906,323 11,070,045 9,581,903
Operating expenses:
Sales and
marketing 1,216,568 995,759 3,840,155 3,188,978
Research and
development 1,032,100 992,839 3,083,438 2,895,436
General and
administrative 1,143,930 1,272,031 3,668,573 3,385,737
Total operating
expenses 3,392,598 3,260,629 10,592,166 9,470,151
Income from operations 251,360 645,694 477,879 111,752
Other income, net 131,925 295,332 414,655 611,882
Minority interest -- 19,178 5,430 59,208
Income before income
tax expense 383,285 960,204 897,964 782,842
Income tax expense 264,459 364,430 770,486 673,245
Net income $118,826 $595,774 $127,478 $109,597
Net income per common share:
Basic $0.01 $0.05 $0.01 $0.01
Diluted $0.01 $0.05 $0.01 $0.01
Weighted average shares
used in the calculation
of net income per common
share:
Basic 13,076,315 12,623,339 12,956,971 12,659,347
Diluted 14,730,290 12,758,058 13,729,676 12,903,526
CONDENSED CONSOLIDATED BALANCE SHEETS
Sept. 30, 2003 Dec. 31, 2002
(unaudited)
ASSETS
Current Assets
Cash and cash equivalents $11,290,949 $15,720,860
Accounts receivable, net 1,155,884 1,074,421
Inventories, net 948,816 807,382
Prepaid expenses and other current assets 607,365 462,442
Deferred income taxes 36,147 36,147
Total Current Assets 14,039,161 18,101,252
Investments available for sale 10,687,813 6,630,771
Furniture, fixtures & equipment, net 1,741,506 1,935,424
Goodwill, net 1,173,102 533,031
Intangible assets, net 1,889,577 1,957,359
Deferred income taxes 172,318 149,498
Total Assets $29,703,477 $29,307,335
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable $1,164,736 $1,011,032
Accrued liabilities 1,204,232 2,347,702
Income taxes payable 591,806 341,172
Total Current Liabilities 2,960,774 3,699,906
Minority interest -- 325,371
Commitments and contingencies
Stockholders' Equity
Preferred stock - $.001 par value;
2,000,000 shares authorized; no
shares issued or outstanding -- --
Common stock - $.001 par value;
56,000,000 shares authorized;
13,364,198 and 12,876,314 shares
issued; and 13,138,898 and
12,651,014 shares outstanding
at September 30, 2003 and
December 31, 2002, respectively 13,365 12,877
Additional paid in capital 57,366,350 55,966,589
Accumulated other comprehensive loss (155,646) (88,564)
Accumulated deficit (29,762,765) (29,890,243)
Treasury stock at cost, 225,300
shares at September 30, 2003
and at December 31, 2002 (718,601) (718,601)
Total Stockholders' Equity 26,742,703 25,282,058
Total Liabilities and Stockholders'
Equity $29,703,477 $29,307,335
Source: SRS Labs, Inc.
|
![]()
|